HiFiBiO Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05789069) | HiFiBiO Therapeutics | 2023-05-09 |
| A Study of HFB301001 in Adult Patients With Advanced Solid Tumors (NCT05229601) | HiFiBiO Therapeutics | 2022-04-20 |
| A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05238883) | HiFiBiO Therapeutics | 2022-03-10 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Healthy Adults (NCT05275660) | HiFiBiO Therapeutics | 2021-05-09 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults (NCT04590430) | HiFiBiO Therapeutics | 2020-10-20 |
Track HiFiBiO Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.